Editorially Independent content supported with advertising by Genentech
Yasha S. Modi, MD
Show Description +
What happens when a patient who presents with intermediate AMD returns with wet AMD and a massive pigment epithelial detachment (PED)? And after switching anti-VEGF agents to achieve longer durability, how do you account for vision loss despite resolution of exudative activity? Yasha S. Modi, MD, reviews this case with Priya Sharma Vakharia, MD, and Joseph M. Coney, MD, and showcases it alongside another PED case, featured in the Part 2 of this video pairing.
Posted: 1/15/2024
Yasha S. Modi, MD
What happens when a patient who presents with intermediate AMD returns with wet AMD and a massive pigment epithelial detachment (PED)? And after switching anti-VEGF agents to achieve longer durability, how do you account for vision loss despite resolution of exudative activity? Yasha S. Modi, MD, reviews this case with Priya Sharma Vakharia, MD, and Joseph M. Coney, MD, and showcases it alongside another PED case, featured in the Part 2 of this video pairing.
Posted: 1/15/2024
Please log in to leave a comment.